Abstract
A recent study from China suggests that high temperature and ultraviolet (UV) radiation cannot decrease the epidemics of Coronavirus disease 2019 (Covid-19). To determine whether COVID-19 incidence is modulated by meteorological factors, meta-regression of Japanese prefectural data was herein conducted. We extracted 1) cumulative numbers of confirmed Covid-19 patients in each Japanese prefecture from January to April 2020; 2) populations per 1-km2 inhabitable area in each prefecture in 2020; and 3) meteorological factors at each prefectural capital city from January to April 2020. Meteorological factors included monthly mean air temperature (°C), wind speed (m/s), sea level air pressure (hPa), relative humidity (%), and percentage of possible sunshine (%); monthly total of sunshine duration (h) and precipitation (mm); and monthly mean daily maximum ultraviolet (UV) index. To adjust for prefectural population density, we defined the incidence of Covid-19 as the cumulative number of Covid-19 patients divided by the population per 100-km2 inhabitable area. Random-effects meta-regression was performed, and its graph depicted Covid-19 incidence (plotted as the logarithm transformed incidence on the y-axis) as a function of a given meteorological factor (plotted on the x-axis). A slope of the meta-regression line was significantly negative as a function of the mean air temperature (coefficient, −0.127; P = 0.023), the mean sea level air pressure (coefficient, −0.351; P < 0.001), and the mean daily maximum UV index (coefficient, −0.001; P = 0.012) which indicated that Covid-19 incidence decreased significantly as air temperature, air pressure, and UV increased. In conclusion, higher air temperature, air pressure, and UV may be associated with less Covid-19 incidence.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.